TAMER MOHAMED to Myocardial Infarction
This is a "connection" page, showing publications TAMER MOHAMED has written about Myocardial Infarction.
Connection Strength
1.436
-
Transient gene therapy using cell cycle factors reverses renin-angiotensin-aldosterone system activation in heart failure rat model. Mol Cell Biochem. 2023 Jun; 478(6):1245-1250.
Score: 0.466
-
Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure. Circulation. 2022 04 26; 145(17):1339-1355.
Score: 0.442
-
Pyruvate kinase splice variants in fibroblasts influence cardiac remodeling after myocardial infarction in male mice. J Mol Cell Cardiol. 2025 Sep; 206:11-26.
Score: 0.140
-
Improved Cardiac Function in Postischemic Rats Using an Optimized Cardiac Reprogramming Cocktail Delivered in a Single Novel Adeno-Associated Virus. Circulation. 2023 10 03; 148(14):1099-1112.
Score: 0.123
-
PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia. Sci Rep. 2021 01 15; 11(1):1518.
Score: 0.103
-
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. Cell. 2018 03 22; 173(1):104-116.e12.
Score: 0.084
-
Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming. Circulation. 2017 Mar 07; 135(10):978-995.
Score: 0.077